Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT...

11
1 Supporting Information Inhibition of Phosphatidylinositol-3,4,5-trisphosphate Binding to AKT Pleckstrin Homology Domain by 4-Amino-1,2,5- oxadiazole Derivatives Sukhamoy Gorai, a Saurav Paul, a Ganga Sankaran, b Rituparna Borah, a Manas Kumar Santra ,b and Debasis Manna ,a a Department of Chemistry, Indian Institute of Technology Guwahati, Assam 781039, India. Fax: +91-03 61258 2350; Tel: +91-03 61258 2325; E-mail: [email protected] b National Center for Cell Science, Pune 411007, Maharashtra, India. Fax: +91- 02025692259; Tel: +91-02025708150; E-mail: [email protected] Table of Content Sl. No Content Page (I) The inhibitory effects of compounds on the interaction between AKT1-PH domain and PI(3,4,5)P 3 S2 (II) Relative Inhibitory Activity of the Compounds Measured by Competitive-Surface Plasmon Resonance Analysis S3 (III) Representative protein-to-membrane FRET experiment under liposomal environment S3 (IV) Representative isothermal titration calorimetric plots of AKT1 PH- domain with potent compounds S4 (V) Lig-plot analysis S5-S6 (VI) Theoretically calculated Interaction Energy between Ligand and PH-domains S7 (VII) Surface representation of the docking complexes S8 (VIII) Anisotropy Values of the Membrane Sensitive Probes in the Presence and Absence of the compounds S9 Electronic Supplementary Material (ESI) for MedChemComm. This journal is © The Royal Society of Chemistry 2015

Transcript of Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT...

Page 1: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

1

Supporting Information

Inhibition of Phosphatidylinositol-3,4,5-trisphosphate Binding

to AKT Pleckstrin Homology Domain by 4-Amino-1,2,5-

oxadiazole Derivatives Sukhamoy Gorai,a Saurav Paul,a Ganga Sankaran,b Rituparna Borah,a Manas Kumar

Santra,b and Debasis Manna,a

aDepartment of Chemistry, Indian Institute of Technology Guwahati, Assam 781039,

India. Fax: +91-03 61258 2350; Tel: +91-03 61258 2325; E-mail: [email protected] bNational Center for Cell Science, Pune 411007, Maharashtra, India. Fax: +91-

02025692259; Tel: +91-02025708150; E-mail: [email protected]

Table of Content Sl. No Content Page (I) The inhibitory effects of compounds on the interaction between

AKT1-PH domain and PI(3,4,5)P3 S2

(II) Relative Inhibitory Activity of the Compounds Measured by Competitive-Surface Plasmon Resonance Analysis

S3

(III) Representative protein-to-membrane FRET experiment under liposomal environment

S3

(IV) Representative isothermal titration calorimetric plots of AKT1 PH-domain with potent compounds

S4

(V) Lig-plot analysis S5-S6 (VI) Theoretically calculated Interaction Energy between Ligand and

PH-domains S7

(VII) Surface representation of the docking complexes S8 (VIII) Anisotropy Values of the Membrane Sensitive Probes in the

Presence and Absence of the compounds S9

Electronic Supplementary Material (ESI) for MedChemComm.This journal is © The Royal Society of Chemistry 2015

Page 2: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

2

Supporting Information

Figure S1: The inhibitory effects of compounds on the interaction between AKT1-PH domain and PI(3,4,5)P3. Representative SPR sensorgrams of AKT1-PH domain binding to the PI(3,4,5)P3 containing liposomes in the presence of increasing concentrations of the compounds PI-2 (A), PI-3 (B) and PI-5 (C).

(A) (B)

0

200

400

600

800

1000

0 200 400 600 800

Rel

ativ

e R

espo

nse

Uni

t (R

U)

Time (S)

0 M

10 M

20 M50 M

100 M500 M

PI-3

0

100

200

300

400

500

600

0 200 400 600 800

Rel

ativ

e R

espo

nse

Uni

t (R

U)

Time (S)

0 M

10 M20 M50 M

100 M

PI-2

(C)

0

200

400

600

800

0 200 400 600 800

Rel

ativ

e R

espo

nse

Uni

t (R

U)

Time (S)

0 M

10 M

20 M

50 M100 M200 M

PI-5

Page 3: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

3

Table S1: Relative Inhibitory Activity of the Compounds Measured by Competitive-Surface Plasmon Resonance Analysis Compound Relative inhibitory activity (%) IC50 values (μM)

Tapp1-PH PLCδ1-PH Tapp1-PH PLCδ1-PH PI-1 28 ± 3 54 ± 6 8.5 ± 0.99 9.6 ± 1.71 PI-3 18 ± 2 46 ± 3 22.1 ± 2.49 3.4 ± 0.41 PI-4 5 ± 2 28 ± 3 286 ± 19.6 34 ± 3.39

Figure S2: Representative protein-to-membrane FRET experiment under liposomal environment. Addition of increased concentration of compounds, PI-1 (A) and PI-4 (B) to AKT1-PH domain (2 μM) bound to the active liposome (PC/PE/PS/dPE/PI(3,4,5)P3 (56/20/20/1/3)) decreases the FRET signal at 509 nm. All the measurements were performed in 20 mM Tris, pH 7.4 containing 160 mM NaCl. Compound concentrations were varied from 0 to 70 μM.

0

2 104

4 104

6 104

8 104

1 105

1.2 105

1.4 105

300 350 400 450 500 550

2 uM AKT-PH 2 uM AKT-PH + 1 uM PI-42 uM AKT-PH + 2 uM PI-42 uM AKT-PH + 5 uM PI-42 uM AKT-PH + 10 uM PI-42 uM AKT-PH + 20 uM PI-42 uM AKT-PH + 30 uM PI-42 uM AKT-PH + 40 uM PI-42 uM AKT-PH + 50 uM PI-42 uM AKT-PH + 60 uM PI-42 uM AKT-PH + 70 uM PI-42 uM AKT-PH + 80 uM PI-4

Fluo

resc

ence

Inte

nsity

(a.u

.)

Wavelength (nm)

0

5 104

1 105

1.5 105

2 105

300 350 400 450 500 550

2 uM AKT-PH2 uM AKT-PH + 1 uM PI-12 uM AKT-PH + 2 uM PI-12 uM AKT-PH + 5 uM PI-12 uM AKT-PH + 10 uM PI-12 uM AKT-PH + 20 uM PI-12 uM AKT-PH + 30 uM PI-12 uM AKT-PH + 40 uM PI-12 uM AKT-PH + 50 uM PI-12 uM AKT-PH + 60 uM PI-12 uM AKT-PH + 70 uM PI-1

Fluo

resc

ence

Inte

nsity

(a.u

.)

Wavelength (nm)

(A) (B)

Page 4: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

4

Figure S3: Representative isothermal titration calorimetric plots of AKT1 PH-domain

with potent compounds. Original titration and integrated peak areas of AKT1 PH-domain

with PI-1 (A) and PI-4 (B).

(A) (B)

Page 5: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

5

(A)(A)

(C)(B)

Page 6: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

6

Figure S4: Lig-plot analysis of IP4 bound to AKT1 PH (1H10) domain (A). Lig-plot

analysis of PI-1 (B) and PI-4 (C) docked into the PIP-binding site of AKT1-PH domain.

Residues involved in interactions through hydrogen bond formation are shown using

dashed lines.

(C)

Page 7: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

7

Table S2: Theoretically calculated Interaction Energy between Ligand and PH-domains

Protein

Ligand

Interaction energy between ligand and Protein (kcal/mol)

Hydrogen bonding energy (kcal/mol)

PIP-binding site

Non PIP-binding site

PIP-binding site

Non PIP-binding site

AKT1-PH

Domain

PI-1 -096.413 -086.471 -18.895 -14.628 -094.055 -086.289 -17.347 -15.559 -092.162 -083.097 -18.140 -13.026

PI-2 -118.573 -108.961 -23.223 -27.636 -111.341 -108.642 -20.653 -16.525 -110.922 -103.784 -19.252 -18.999

PI-3 -127.659 -118.369 -24.080 -27.361 -126.770 -112.789 -28.646 -15.482 -125.818 -120.384 -23.513 -23.033

PI-4 -118.527 -115.097 -25.753 -15.362 -119.380 -116.788 -18.622 -21.403 -117.506 -111.003 -16.348 -14.046

PI-5 -122.965 -114.062 -24.391 -12.146 -115.767 -109.465 -19.299 -15.455 -115.395 -109.266 -23.840 -08.255

Grp1-PH Domain

PI-1 -92.8201 - -21.959 - -90.6866 - -19.842 - -89.9794 - -22.223 -

PI-2 -113.564 - -24.156 - -112.836 - -22.030 - -112.737 - -25.896 -

PI-3 -131.210 - -28.362 - -129.856 - -28.363 - -122.495 - -29.276 -

PI-4 -126.288 - -23.785 - -124.609 - -18.588 - -124.401 - -22.979 -

PI-5 -131.210 - -28.362 - -129.856 - -28.363 - -122.495 - -29.276 -

BTK-PH Domain

PI-1 -112.621 -140.259 -23.995 -20.284 -110.963 -138.152 -23.616 -23.426 -101.816 -136.625 -10.688 -20.842

PI-4 -127.118 -152.321 -21.303 -20.958 -126.359 -141.947 -23.870 -23.407 -125.421 -141.484 -25.414 -25.204

Page 8: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

8

Figure S5: Surface representation of the docking complexes AKT1-PH/PI-1 (A), AKT1-

PH/PI-4 (B) and AKT1-PH/PIT-1 (C) both in PIP (yellow circle) and PS- (pink square

box) binding sites. Overall surface of AKT1-PH domain was colored according to the

electrostatic potential (blue, positively charged; red, negatively charged; white, neutral)

using PyMOL software.

PIP binding Site(A)

PS-binding site

PIP binding Site

PS-binding site

(B)

(C)

PS-binding site

PIP binding Site

Page 9: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

9

Table S3: Anisotropy Values of the Membrane Sensitive Probes in the Presence and Absence of the compounds

Compound Anisotropy of DPH Anisotropy of NBD-PE liposome 0.2704 ± 0.0128 0.2117 ± 0.0128

PI-1 0.2599 ± 0.0286 0.1744 ± 0.0262 PI-2 0.2625 ± 0.0122 0.1855 ± 0.0248 PI-3 0.2595 ± 0.0135 0.1909 ± 0.0011 PI-4 0.2536 ± 0.0025 0.1614 ± 0.0026 PI-5 0.2574 ± 0.0116 0.1704 ± 0.0125

Values in parentheses indicate standard deviations.

Page 10: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

10

Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells. MDA-

MB-231 cells were treated with the compounds (25 μM) for 48 h, and the indicated

PI(3,4,5)P3-dependent phosphorylation events were evaluated by immunoblot analysis

(A). MDA-MB-231 cells were treated with the PI-1 and PI-4 with different

concentrations (5, 10 and 25 μM) for 48 h, and the indicated PI(3,4,5)P3-dependent

phosphorylation events were evaluated by immunoblot analysis (B and C). All the

immunoblot images were presented in grey scale for better clarity. All cellular

measurements were performed more than five times. Normalized expression level of

pThr308 of AKT enzyme in the absence and presence of compounds with 25 μM

(D) (E)

T-Akt

pSer-473

Tubulin

pThr-308

T-Akt

pThr-308

Tubulin

pThr-308T-Akt

Tubulin

(A) (B)

(C)

0

20

40

60

80

100

120

ControlPI-1; 25 uMPI-3; 25 uMPI-4; 25 uMPI-5; 25 uM

Nor

mal

ized

Exp

ress

ion

leve

l of

pTh

r308

-AKT

Control PI-1 PI-3 PI-4 PI-5

0

20

40

60

80

100

120

0 5 10 25

PI-1PI-4

Nor

mal

ized

Exp

ress

ion

leve

l of

pTh

r308

-AK

T

Concentration (M)

Page 11: Inhibition of Phosphatidylinositol-3,4,5-trisphosphate ... · 10 Figure S6: Compounds inhibit AKT signalling pathway in MDA-MB-231 cells.MDA-MB-231 cells were treated with the compounds

11

concentrations (D). Normalized expression level of pThr308 of AKT enzyme in the

absence and presence of PI-1 and PI-4 compounds in a concentration dependent manner

(0, 5, 10, 25 μM) (E).